What is the relationship between type 1 diabetes and bone fractures?

Bad blood sugar control puts people with type 1 diabetes in a higher risk of fragility fractures, shows a recent study.

A fracture due to fragility is a bone fracture caused by a fall from a height of thirty centimeters or less.

In the study, the researchers analyzed data of more than 3,300 people with type 1 diabetes and more than 44,000 people with type 2 diabetes, in the United Kingdom.

The data included an average three years of the Patient's Blood Analysis.That test measures the average blood sugar levels of a patient over two to three months.On average, there were nine A1C measurements among patients with type 1 diabetes, and 11 among patients with type 2 diabetes.

A bad blood sugar control (of glycemia) with a level of A1C greater than 8 percent was linked to a greater risk of fragility fractures in people with type 1 diabetes, but not among those who had type 2 diabetes, according to the study, which appears in the January 16 edition of the Journal of Clinical Endocrinology & AMP;Metabolism.

"We investigate the association between the degree of blood glucose control and the risk of fracture using a large cohort of patients with type 1 diabetes and type 2 newly diagnosed," said the study co -author, Dr. Janina Vavanikunnel, of the Department of Endocrinology, Diabetology and Metabolism of the Hospital of the University of Basel, in Switzerland.

"Both types of diabetes are associated with fragility fractures, and we show that bad blood glucose control is associated with a greater risk of fractures in type 1 diabetes," Vavanikunnel said in a press release from the University, collected by HealthdayNews.

The risk of fracture in type 2 diabetes is probably due to factors apart from blood sugar control, for example, diabetes related health problems, according to study authors.

Even so, said the study co -author, Sarah Charlier, "the risk of fracture in type 2 diabetes also has clinical relevance as an important health problem worldwide, due to its high prevalence."Charlier is a pharmacoepidemióloga at the Hospital of the University of Basel.